Anja Schmidt, Christopher C Winchester, Catherine Skobe, Diane R Stothard, Eric Topol
Pharmaceutical companies fund much biomedical research, yet many journals restrict open access publishing options for peer-reviewed articles reporting commercially funded research. Expanded publishing options, such as funder-neutral publishing policies, will help address this inequity.